Melevodopa
Alternative Names: L-dopa-methylester; LDME; Levodopa-methylester; LevometLatest Information Update: 07 Feb 2000
At a glance
- Originator Chiesi
- Class Antiparkinsonians; Aromatic amino acids; Catecholamines; Neuroprotectants; Small molecules
- Mechanism of Action Dopamine receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Parkinson's disease
Most Recent Events
- 07 Feb 2000 Launched for Parkinson's disease in Italy (PO)
- 02 Sep 1999 Registered for Parkinson's disease in Italy (PO)
- 28 Jan 1997 Preregistration for Parkinson's disease in Italy (PO)